Gut microbiota in ALS: possible role in pathogenesis?

Area of Science:

• Microbiology
• Neuroscience
• Gastroenterology

Background:

• The gut microbiota plays a crucial role in human health.
• Microbial metabolites are implicated in neurodegenerative disease pathogenesis, including amyotrophic lateral sclerosis (ALS).

Purpose of the Study:

• To review methods for assessing the gut microbiota.
• To explore the gut microbiota's influence on physiological functions and its theoretical role in ALS pathogenesis.
• To examine current evidence on gut microbiota composition in ALS and potential therapeutic strategies.

Main Methods:

• Literature review of studies on gut microbiota assessment.
• Analysis of research on gut microbiota's role in physiological functions.
• Review of evidence in ALS patients and rodent models.
• Examination of therapies targeting gut dysbiosis.

Main Results:

• Existing studies indicate possible gut dysbiosis in ALS patients and mouse models.
• Current evidence is limited, necessitating larger, well-controlled studies.
• The gut microbiota's role in ALS pathogenesis remains an emerging area of investigation.

Conclusions:

• Gut dysbiosis is potentially linked to ALS pathogenesis, but requires further research.
• Larger studies employing advanced metagenomic techniques are essential to clarify the gut microbiota's role in ALS.
• This field holds significant promise for future therapeutic interventions.